Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers.

about

The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial.Effectiveness of paliperidone extended-release for patients with schizophrenia: focus on subjective improvement.

P2860

Q42618887-F66B1BAA-CE72-4323-BC34-2512ED67FE9F Q48193359-3ACA2221-F206-467A-8F1C-93EDF64B4116

P2860

Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers.

Item

http://www.wikidata.org/entity/Q50757787

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Different safety profiles of r ...... trial with healthy volunteers.

@en

Different safety profiles of r ...... trial with healthy volunteers.

@nl

type

Item

label

Different safety profiles of r ...... trial with healthy volunteers.

@en

Different safety profiles of r ...... trial with healthy volunteers.

@nl

prefLabel

Different safety profiles of r ...... trial with healthy volunteers.

@en

Different safety profiles of r ...... trial with healthy volunteers.

@nl

P1476

Different safety profiles of r ...... trial with healthy volunteers.

@en

P2093

Jong-Chul Yang

http://www.w3.org/2001/XMLSchema#string

Keun-Young Oh

http://www.w3.org/2001/XMLSchema#string

Kil-Sang Yoon

http://www.w3.org/2001/XMLSchema#string

Min-Gul Kim

http://www.w3.org/2001/XMLSchema#string

Myung-Sook Park

http://www.w3.org/2001/XMLSchema#string

Tae-Won Park

http://www.w3.org/2001/XMLSchema#string

Young-Chul Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

The positive and negative syndrome scale (PANSS) for schizophrenia

No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.

Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.

Extended-release paliperidone: efficacy, safety and tolerability profile of a new atypical antipsychotic.

Paliperidone extended-release for the treatment of schizophrenia.

Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.

Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone.

Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs.

Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol.

P304

305-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HUP.2227

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22585590

http://www.w3.org/2001/XMLSchema#string

P921

placebo

Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers.

about

P2860

P2860

Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921